These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26901046)

  • 1. Which Genetics Variants in DNase-Seq Footprints Are More Likely to Alter Binding?
    Moyerbrailean GA; Kalita CA; Harvey CT; Wen X; Luca F; Pique-Regi R
    PLoS Genet; 2016 Feb; 12(2):e1005875. PubMed ID: 26901046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of breast cancer associated variants that modulate transcription factor binding.
    Liu Y; Walavalkar NM; Dozmorov MG; Rich SS; Civelek M; Guertin MJ
    PLoS Genet; 2017 Sep; 13(9):e1006761. PubMed ID: 28957321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the identification of potential regulatory variants within genome wide association candidate SNP sets.
    Chen CY; Chang IS; Hsiung CA; Wasserman WW
    BMC Med Genomics; 2014 Jun; 7():34. PubMed ID: 24920305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GERV: a statistical method for generative evaluation of regulatory variants for transcription factor binding.
    Zeng H; Hashimoto T; Kang DD; Gifford DK
    Bioinformatics; 2016 Feb; 32(4):490-6. PubMed ID: 26476779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global reference mapping of human transcription factor footprints.
    Vierstra J; Lazar J; Sandstrom R; Halow J; Lee K; Bates D; Diegel M; Dunn D; Neri F; Haugen E; Rynes E; Reynolds A; Nelson J; Johnson A; Frerker M; Buckley M; Kaul R; Meuleman W; Stamatoyannopoulos JA
    Nature; 2020 Jul; 583(7818):729-736. PubMed ID: 32728250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sasquatch: predicting the impact of regulatory SNPs on transcription factor binding from cell- and tissue-specific DNase footprints.
    Schwessinger R; Suciu MC; McGowan SJ; Telenius J; Taylor S; Higgs DR; Hughes JR
    Genome Res; 2017 Oct; 27(10):1730-1742. PubMed ID: 28904015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atlas of Transcription Factor Binding Sites from ENCODE DNase Hypersensitivity Data across 27 Tissue Types.
    Funk CC; Casella AM; Jung S; Richards MA; Rodriguez A; Shannon P; Donovan-Maiye R; Heavner B; Chard K; Xiao Y; Glusman G; Ertekin-Taner N; Golde TE; Toga A; Hood L; Van Horn JD; Kesselman C; Foster I; Madduri R; Price ND; Ament SA
    Cell Rep; 2020 Aug; 32(7):108029. PubMed ID: 32814038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Most brain disease-associated and eQTL haplotypes are not located within transcription factor DNase-seq footprints in brain.
    Handel AE; Gallone G; Zameel Cader M; Ponting CP
    Hum Mol Genet; 2017 Jan; 26(1):79-89. PubMed ID: 27798116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genome-wide screen for genetic variants that modify the recruitment of REST to its target genes.
    Johnson R; Richter N; Bogu GK; Bhinge A; Teng SW; Choo SH; Andrieux LO; de Benedictis C; Jauch R; Stanton LW
    PLoS Genet; 2012; 8(4):e1002624. PubMed ID: 22496669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Explicit DNase sequence bias modeling enables high-resolution transcription factor footprint detection.
    Yardımcı GG; Frank CL; Crawford GE; Ohler U
    Nucleic Acids Res; 2014 Oct; 42(19):11865-78. PubMed ID: 25294828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An expansive human regulatory lexicon encoded in transcription factor footprints.
    Neph S; Vierstra J; Stergachis AB; Reynolds AP; Haugen E; Vernot B; Thurman RE; John S; Sandstrom R; Johnson AK; Maurano MT; Humbert R; Rynes E; Wang H; Vong S; Lee K; Bates D; Diegel M; Roach V; Dunn D; Neri J; Schafer A; Hansen RS; Kutyavin T; Giste E; Weaver M; Canfield T; Sabo P; Zhang M; Balasundaram G; Byron R; MacCoss MJ; Akey JM; Bender MA; Groudine M; Kaul R; Stamatoyannopoulos JA
    Nature; 2012 Sep; 489(7414):83-90. PubMed ID: 22955618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic risk for Alzheimer's disease is concentrated in specific macrophage and microglial transcriptional networks.
    Tansey KE; Cameron D; Hill MJ
    Genome Med; 2018 Feb; 10(1):14. PubMed ID: 29482603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DeFCoM: analysis and modeling of transcription factor binding sites using a motif-centric genomic footprinter.
    Quach B; Furey TS
    Bioinformatics; 2017 Apr; 33(7):956-963. PubMed ID: 27993786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription factor-binding k-mer analysis clarifies the cell type dependency of binding specificities and cis-regulatory SNPs in humans.
    Tahara S; Tsuchiya T; Matsumoto H; Ozaki H
    BMC Genomics; 2023 Oct; 24(1):597. PubMed ID: 37805453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prioritizing cardiovascular disease-associated variants altering NKX2-5 and TBX5 binding through an integrative computational approach.
    Peña-Martínez EG; Pomales-Matos DA; Rivera-Madera A; Messon-Bird JL; Medina-Feliciano JG; Sanabria-Alberto L; Barreiro-Rosario AC; Rivera-Del Valle J; Rodríguez-Ríos JM; Rodríguez-Martínez JA
    J Biol Chem; 2023 Dec; 299(12):105423. PubMed ID: 37926287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factor-DNA binding: beyond binding site motifs.
    Inukai S; Kock KH; Bulyk ML
    Curr Opin Genet Dev; 2017 Apr; 43():110-119. PubMed ID: 28359978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and structural considerations of TF-DNA binding for the generation of biologically meaningful and accurate phylogenetic footprinting analysis: the LysR-type transcriptional regulator family as a study model.
    Oliver P; Peralta-Gil M; Tabche ML; Merino E
    BMC Genomics; 2016 Aug; 17(1):686. PubMed ID: 27567672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-binding factor footprints and enhancer RNAs identify functional non-coding genetic variants.
    Biddie SC; Weykopf G; Hird EF; Friman ET; Bickmore WA
    Genome Biol; 2024 Aug; 25(1):208. PubMed ID: 39107801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. atSNP: transcription factor binding affinity testing for regulatory SNP detection.
    Zuo C; Shin S; Keleş S
    Bioinformatics; 2015 Oct; 31(20):3353-5. PubMed ID: 26092860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative analysis of liver-specific non-coding regulatory SNPs associated with the risk of coronary artery disease.
    Selvarajan I; Toropainen A; Garske KM; López Rodríguez M; Ko A; Miao Z; Kaminska D; Õunap K; Örd T; Ravindran A; Liu OH; Moreau PR; Jawahar Deen A; Männistö V; Pan C; Levonen AL; Lusis AJ; Heikkinen S; Romanoski CE; Pihlajamäki J; Pajukanta P; Kaikkonen MU
    Am J Hum Genet; 2021 Mar; 108(3):411-430. PubMed ID: 33626337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.